The InnoSIGN team is excited to meet you at this year’s AMP Annual Meeting & Expo in Salt Lake City, US, from Tuesday November 14 to Saturday 18 November, 2023.
Applications of OncoSIGNal pathway profiling platform in breast cancer and bladder cancer will be presented at the InnoSIGN corporate workshop by Dr M Snuderl (Head Pathology (NYU-Langone, US) and Dr. F.C. de Jong (Erasmus Medical Center, NL).
An abstract by Schroff et al. (NYU-Langone) has been selected for oral platform and poster presentation, and an abstract by Van Strijp et al. (InnoSIGN) for poster presentation in the scientific program.
If you want to learn more about the OncoSIGNal platform and applications for clinical and research use we look forward to welcome you at the InnoSIGN booth #1430.
Corporate workshop:
“OncoSIGNal Platform for Analysis of Cell Signaling Pathway Activity Unlocking the Power of Personalized Targeted Therapies”
Wednesday, November 15 | 3:00pm – 3:50pm
Posters & platform presentations:
“Targeted RNA expression-based signaling pathway analysis of epigenetic subtypes of triple negative breast cancers identifies mutation-independent pathway activation”
Platform presentation by M. Snuderl, MD (NYU Langone, US) | Thursday, November 16 |
3:00pm – 3:15pm | 255BC, Second Level
Poster # GO26 by Chanel Schroff et al, NYU Langone Health | Friday, November 17 |
9:15am – 10:15am
“A novel Laboratory Developed Test for identification of key tumor driving cell signaling pathways in breast cancer: ER, AR, PI3K, MAPK, Hedgehog, TGFß and Notch”
Poster # ST103 by Dianne van Strijp et al, InnoSIGN | Saturday, November 18 | 9:15am – 10:15am
